DANA-FARBER CANCER INSTITUTE, INC.;NEREUS PHARMACEUTICALS, INC.
发明人:
ANDERSON, KENNETH, C.,CHAUHAN, DHARMINDER,PALLADINO,MICHAEL A.
申请号：
DK05852783
公开号：
DK1830838T3
申请日:
2005.12.02
申请国别(地区):
DK
年份:
2013
代理人:
摘要：
Disclosed herein are compositions and methods for treating neoplastic diseases. Included are compositions and methods that are effective against multiple myeloma cells resistant to conventional and bortezomib treatment. Furthermore, combination treatment with two different proteosome inhibitors is shown to be synergistic for treating multiple myeloma.
